Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
2011 Oncology Nursing Excellence and Clinical Excellence Award winners announced
Chapel Hill - The Oncology Nursing Excellence and Clinical Services Excellence Awards recognize four employees who exemplify the very best in cancer care at UNC Lineberger Comprehensive Cancer Center and UNC Cancer Care.
Located in News / 2011 News
Predictive biomarkers for lung cancer reported in laboratory finding
A team of scientists, including several from UNC Lineberger, has identified predictive genetic biomarkers in pre-clinical models that affect response to therapy for non-small cell lung cancer (NSCLC). The study was done in parallel to an ongoing clinical trial among lung cancer patients at multiple institutions.
Located in News / 2012 News
Pox, patents and pancreatic cancer vaccines
Rachel Roper, PhD, Associate Professor of Microbiology & Immunology at East Carolina’s Brody School of Medicine has been granted a patent for her discovery of a poxvirus gene that, when deleted, significantly weakens the vaccine virus while simultaneously increasing immune responses to it.
Located in News / 2012 News
Damania, Dittmer talk about new global oncology program
Blossom Damania, PhD, and Dirk Dittmer, PhD, both have lived all over the world, where they saw firsthand the global burden of cancer. Both are professors of microbiology and immunology in the UNC school of Medicine and members of UNC Lineberger.
Located in News / 2012 News
UNC Lineberger member Kurt Ribisl co-authors study assessing online alcohol sales to minors
Kurt Ribisl, PhD, is co-author of the article “Internet Alcohol Sales to Minors” published online ahead of print in the May 2012 issue of the Archives of Pediatrics & Adolescent Medicine.
Located in News / 2012 News
PSA test discussed, Brewer quoted
Located in News / 2012 News
UNC Lineberger patient Morgan Throckmorton talks with WRAL about her diagnosis, clinical trials
UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.
Located in News / 2011 News
UNC Scientists Create "Excellent" Probe to Study Gene-Controlling Proteins
Collaboration between University of North Carolina at Chapel Hill and Canadian scientists has resulted in a molecular probe capable of specifically targeting two proteins that affect a wide range of biological functions in humans by controlling the expression of certain genes.
Located in News / 2011 News
Scarring a necessary evil to prevent further damage after heart attack
CHAPEL HILL, N.C. – After a heart attack, the portions of the heart damaged by a lack of oxygen become scar tissue. Researchers have long sought ways to avoid this scarring, which can harden the walls of the heart, lessen its ability to pump blood throughout the body and eventually lead to heart failure. But new research from the University of North Carolina at Chapel Hill School of Medicine shows that interrupting this process can weaken heart function even further.
Located in News / 2011 News
Editorial urges rapid clinical trials for targeted breast cancer therapies
Chapel Hill, NC – In an editorial published today in the Journal of Clinical Oncology, UNC associate professor E. Claire Dees, MD, reviews current evidence on the safety and efficacy of combination therapies currently used for metastatic breast cancer and urges clinical researchers to move forward with new studies that leverage advances in the identification of tumor biomarkers.
Located in News / 2011 News